Study of an RSV-hMPV-PIV3 Trivalent Vaccine Candidate VXB-251 in Older Adults
Study of an RSV-hMPV-PIV3 Trivalent Vaccine Candidate VXB-251 in Older Adults
Active, not recruiting · NCT07295028 · Registry updated 2026-05-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of an RSV-hMPV-PIV3 Trivalent Vaccine Candidate VXB-251 in Older Adults | lower respiratory tract disorder | Active, not recruiting | Phase 1 | 2026-05-20 | NCT07295028 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sanofi | 254 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Emeritus Research | Camberwell | Australia | 1 |
| Momentum Clinical Research | Darlinghurst | Australia | 1 |
| University of Sunshine Coast, South Bank | Brisbane | Australia | 1 |
| University of the Sunshine Coast | Morayfield | Australia | 1 |
| University of the Sunshine Coast, Sippy Downs | Sippy Downs | Australia | 1 |
| Veritus Research | Melbourne | Australia | 3 |